Cresco Labs (Cresco Labs) FCF Margin % : 16.23% (As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cresco Labs's Free Cash Flow for the three months ended in Mar. 2024 was $29.9 Mil. Cresco Labs's Revenue for the three months ended in Mar. 2024 was $184.3 Mil. Therefore, Cresco Labs's FCF Margin % for the quarter that ended in Mar. 2024 was 16.23%.

As of today, Cresco Labs's current FCF Yield % is 6.72%.

The historical rank and industry rank for Cresco Labs's FCF Margin % or its related term are showing as below:

CRLBF' s FCF Margin % Range Over the Past 10 Years
Min: -94.38 Med: -10.05 Max: 6.37
Current: 6.37

During the past 13 years, the highest FCF Margin % of Cresco Labs was 6.37%. The lowest was -94.38%. And the median was -10.05%.

CRLBF's FCF Margin % is ranked better than
68.16% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs CRLBF: 6.37

Cresco Labs FCF Margin % Historical Data

The historical data trend for Cresco Labs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs FCF Margin % Chart

Cresco Labs Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-94.38

-20.39

-10.05

-8.00

0.09

Cresco Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-9.21	-0.11	14.30	-4.51	16.23

Competitive Comparison of Cresco Labs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cresco Labs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cresco Labs's FCF Margin % falls into.

Cresco Labs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cresco Labs's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	0.681	/	770.885
	=	0.09 %

Cresco Labs's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	29.919	/	184.295
	=	16.23 %

Cresco Labs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cresco Labs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs (Cresco Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (OTCPK:CRLBF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

6CQ:Germany CL:Canada

Address

400 W. Erie Street, Suite 110, Chicago, IL, USA, 60654

Website

https://www.crescolabs.com

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and third-party retail stores. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.